Classys Inc 214150
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩54,300.00
- Day Range
- ₩54,000.00–56,200.00
- 52-Week Range
- —–—
- Bid/Ask
- ₩56,000.00 / ₩56,100.00
- Market Cap
- —
- Volume/Avg
- 213,651 / 176,662
Key Statistics
- Price/Earnings (Normalized)
- 41.47
- Price/Sales
- 17.61
- Dividend Yield (Trailing)
- 0.36%
- Dividend Yield (Forward)
- 0.36%
- Total Yield
- 0.76%
Company Profile
Classys Inc is engaged in the manufacturing of medical and dental instruments and supplies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 399
- Website
- http://www.classys.co.kr
Comparables
Valuation
|
Metric
|
214150
|
290650
|
145720
|
|---|---|---|---|
Price/Earnings (Normalized) | 41.47 | 63.92 | 7.51 |
Price/Book Value | 11.14 | 3.06 | 1.44 |
Price/Sales | 17.61 | 6.25 | 1.76 |
Price/Cash Flow | 40.29 | 309.01 | 6.62 |
Price/Earnings
214150
290650
145720
Financial Strength
|
Metric
|
214150
|
290650
|
145720
|
|---|---|---|---|
Quick Ratio | 1.80 | 0.69 | 0.89 |
Current Ratio | 2.01 | 1.23 | 1.47 |
Interest Coverage | 57.37 | — | 20.28 |
Quick Ratio
214150
290650
145720
Profitability
|
Metric
|
214150
|
290650
|
145720
|
|---|---|---|---|
Return on Assets (Normalized) | 22.73% | 19.67% | 12.53% |
Return on Equity (Normalized) | 30.38% | 36.67% | 21.01% |
Return on Invested Capital (Normalized) | 23.91% | 21.23% | 14.84% |
Return on Assets
214150
290650
145720
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Skyrwqf | Zdvpbvf | $195.6 Bil | |||
| Stryker Corp
SYK
| Hsdtfdvbh | Rhkqk | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Sbjrdvqk | Skmljb | $122.7 Bil | |||
| Medtronic PLC
MDT
| Yndkhhbw | Wxgczq | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Zhbtqfjs | Zgbqgh | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Nwvl | Gmwz | $30.7 Bil | |||
| DexCom Inc
DXCM
| Bjtzvzdhv | Ltq | $27.0 Bil | |||
| Steris PLC
STE
| Ndlxldz | Gddytv | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Mzrzdwjgd | Txjc | $22.0 Bil | |||
| Insulet Corp
PODD
| Rnchbkxs | Mjrzfwj | $16.3 Bil |
United States